Action 17
Engage in early and regular consultations with the PAWG on PIP/PSPs, as well as recommended dosing and ratios for FDC development.
Committed by:
Pharmaceutical companies
Sub-Actions & Milestones
Sub-action 17.2
Recommend dosing and ratios for FDC development.
-
-
-
Milestone 17.2.1
-
-
-
-
Document (s)
-
-
-
-
Sub-action 17.1
Engage in early and regular consultations with the PAWG on PIP/PSPs
Pharmaceutical Companies
-
-
Milestone 17.1.1
-
-
-
-
Document (s)
-
-
-
-
Updates
Notes
Responsible